Karin S. Walsh, Psy.D.

  • Co-Director, Pre-Doctoral Externship Training Program, Pediatric Neuropsychology
  • Pediatric Neuropsychologist
    • B.A., Clinical Psychology, Youngstown State University, Youngstown, OH, (1990-1994)
    • M.A., Clinical Psychology, Loyola University, Baltimore, MD, (1994-1997)
    • Psy.D., Clinical Psychology, Loyola University, Baltimore, MD, (2000-2004)
    • Post-Doc, Pediatric Neuropsychology, Mount Washington Pediatric Hospital, Baltimore, MD, (2004-2006)
  • Karin S. Walsh, Psy.D., holds a doctoral degree in clinical psychology and received advanced post-doctoral training in pediatric neuropsychology. She is a pediatric neuropsychologist in the Division of Neuropsychology at Children’s National Hospital and an Associate Professor of Pediatrics and Psychiatry & Behavioral Medicine at the George Washington University School of Medicine and Health Services. She has 16 years’ experience as a clinical neuropsychologist and scientist caring for and studying children with blood disorders including leukemia and hemophilia, pediatric brain tumors, and genetic disorders such as neurofibromatosis type 1 and other RASopathies.

    Dr. Walsh is an active clinical researcher who has received multiple grants for her research. She conducts research and publishes in the areas of cognitive outcomes in pediatric cancers, hematologic disorders and congenital disorders, with particular focus on executive functions. She is also involved in intervention research, specifically targeting learning and executive function difficulties in pediatric clinical populations.

    Her expertise has resulted in her serving as a consultant or reviewer to various private and federal organizations including the Department of Defense and pharmaceutical companies. Dr. Walsh holds several leadership positions in international committees and groups. She is the current president of the Posterior Fossa Society, current chair of the Neurocognitive Committee within the NF Clinical Trials Consortium, and previous chair of the neurocognitive committee for the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) working group. She is also a member of multiple working groups and scientific committees focused on developing and carrying out high level research that will ultimately benefit children and families affected by acquired and congenital disorders. Finally, Dr. Walsh is an active participant in the education and mentorship of pre- and post-doctoral students and junior faculty in psychology, neuropsychology and medicine.